Sign in
CompletedNo phase

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Key facts

Who runs it
Oslo University Hospital
Where
Norway3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
89 people enrolled
Started
10 Dec 2021
Ended
31 Aug 2024
Type of study
Observational
Record updated
27 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Genetically confirmed Myotonic Dystrophy type 1

Who cannot take part

  • Unable to answer or understand questionnaires due to language barriers or cognitive status
  • Unable to perform functional tests

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
27 April 2025